Johnson & Johnson (NYSE:JNJ)
| 160.12 Delayed Data As of Oct 18 |  -1.18 / -0.73%Today’s Change | 133.65 Today|||52-Week Range 179.92 | +1.74% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 161.30 |
| Today’s open | 160.25 |
| Day’s range | 159.20 - 160.89 |
| Volume | 46,102 |
| Average volume (3 months) | 6,082,936 |
| Market cap | $424.6B |
Data as of 5:53pm ET, 10/18/2021
Growth & Valuation
| Earnings growth (last year) | -2.22% |
| Earnings growth (this year) | +20.99% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +0.56% |
| P/E ratio | 24.1 |
| Price/Sales | 5.09 |
| Price/Book | 6.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.01 | +0.02% |
| LLYEli Lilly and Co | -0.04 | -0.02% |
| MRKMerck | -1.18 | -1.51% |
| ABBVAbbVie | -0.01 | -0.01% |
Data as of 5:56pm ET, 10/18/2021
Financials
| Last reporting date | October 19, 2021 |
| EPS forecast (this quarter) | $2.35 |
| Annual revenue (last year) | $82.6B |
| Annual profit (last year) | $14.7B |
| Net profit margin | 17.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
